Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vaccines Helped GSK Post Strong Q1 Results Ahead Of RSV Approval

Looks Ahead To Second Season Data

Apr 26 2023

• By Alexandra Shimmings

Emma Walmsley GSK — Dame Emma Walmsely • Source: GSK

Related Content

GSK Boosts Its Infectious Disease Portfolio With Brexafemme License

Mar 30 2023

Both Pfizer And GSK RSV Vaccines Set For Approval – But Could Next Readouts Give One The Edge?

Mar 06 2023

GSK Sees Blockbuster Chronic Cough Opportunity With $2bn Bellus Buyout

Apr 18 2023

Related Companies

GSK plc

Pfizer Inc.

BELLUS Health Inc.

Additional Topics

Sales & Earnings Companies Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.